ILMN Stocktwits, News and Mentions. Forecasting Illumina, Inc. Sentiments







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

ILMN Stock News and Mentions of Illumina, Inc. Stocktwits

Updated: March 28, 2024 (13:18)

Sector: Healthcare

Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.

We meticulously analyze the sentiment trend in each article for the last 60 days where Illumina Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Illumina, Inc. (ILMN).

You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Illumina stocks.


Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles

News and Mentions of Illumina, Inc. (ILMN)

March 26, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
In Article Trend: Bullish
March 22, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)

Exact Sciences ( EXAS ) Up 4.2% Since Last Earnings Report: Can It Continue?

Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 21, 2024 (22:37) / "Motley Fool" (by Eric Volkman)

Why Illumina Stock Zoomed Higher on Thursday

The company's chances for winning an important legal battle have improved dramatically.
In Article Trend: Somewhat-Bullish
March 21, 2024 (17:56) / "Benzinga" (by Vandana Singh)

Why Is Illumina Stock Trading Higher On Thursday? - Illumina ( NASDAQ:ILMN )

In a setback for EU antitrust regulators, an adviser to Europe's top court has criticized the decision to block Illumina Inc's ILMN $7.1 billion bid for Grail Inc., stating that they exceeded their powers.
In Article Trend: Neutral
March 18, 2024 (13:44) / "Zacks Commentary" (by Zacks Investment Research)

Labcorp ( LH ) Presents New Research on Precision Diagnostics

Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
In Article Trend: Neutral
March 18, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)

Is Invesco S&P 500 Equal Weight Health Care ETF ( RSPH ) a Strong ETF Right Now?

Smart Beta ETF report for ...
In Article Trend: Somewhat-Bullish
March 16, 2024 (21:05) / "Motley Fool" (by Courtney Carlsen)

Is Icahn Enterprises Stock a Buy?

The stock offers an incredible dividend yield near 29%, but investors should consider the following before buying it.
In Article Trend: Somewhat-Bullish
March 16, 2024 (14:29) / "PR Newswire" (by Laboratory Corporation of America Holdings)

Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer

Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker ... PR ...
In Article Trend: Somewhat-Bullish
March 15, 2024 (14:20) / "Business Insider" (by Matthew Fox)

The Nvidia-led AI boom will eventually spread to these 3 areas of the stock market, Goldman says

Stock Market Outlook: Nvidia's AI Boom to Spread to 3 Groups of Stocks - Markets Insider ...
In Article Trend: Somewhat-Bullish
March 13, 2024 (17:56) / "Benzinga" (by Vandana Singh)

Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts What's Going On With Illumina Stock On Wednesday? - Illumina ( NASDAQ:ILMN )

Activist investor Carl Icahn has opted against pursuing a fresh challenge to Illumina Inc's ILMN board, a move that spares the U.S. gene sequencing company from facing its second proxy battle in consecutive years.
In Article Trend: Neutral
March 13, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)

Should You Invest in the Invesco Biotechnology & Genome ETF ( PBE ) ?

Sector ETF report for ...
In Article Trend: Somewhat-Bullish
March 12, 2024 (11:00) / "PR Newswire"

Element Biosciences Announces Senior Vice President of Global Sales and Support - PR Newswire

Element Biosciences Announces Senior Vice President of Global Sales and Support PR ...
In Article Trend: Somewhat-Bullish
March 7, 2024 (16:46) / "Benzinga" (by Benzinga Insights)

A Closer Look at Illumina's Options Market Dynamics - Illumina ( NASDAQ:ILMN )

Deep-pocketed investors have adopted a bearish approach towards Illumina ILMN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
In Article Trend: Neutral
March 7, 2024 (12:30) / "PR Newswire" (by Moligo Technologies)

Moligo Technologies Appoints John Kuijpers as Chief Business Officer

Kuijpers comes with successful track record growing sales of new technologies, as Moligo accelerates commercial expansion
In Article Trend: Somewhat-Bullish
March 7, 2024 (11:20) / "Zacks Commentary" (by Zacks Equity Research)

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF ( RSPH ) ?

Sector ETF report for ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (11:20) / "Zacks Commentary" (by Zacks Equity Research)

Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now?

Smart Beta ETF report for ...
In Article Trend: Somewhat-Bullish
March 4, 2024 (15:00) / "Benzinga" (by Globe Newswire)

Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024

Researchers present abstracts and poster sessions showcasing research and clinical solutions
In Article Trend: Somewhat-Bullish
March 4, 2024 (14:30) / "Benzinga" (by Globe Newswire)

Spatial Genomics & Transcriptomics Market Anticipated to Reach USD 2 billion, Rising at a CAGR of 17% by 2033: Transparency Market Research, Inc.

Wilmington, Delaware, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global spatial genomics & transcriptomics market is estimated to flourish at a CAGR of 17% from 2023 to 2033.
In Article Trend: Bullish
March 1, 2024 (11:20) / "Zacks Commentary" (by Zacks Equity Research)

Should Invesco S&P 500 Equal Weight ETF ( RSP ) Be on Your Investing Radar?

Style Box ETF report for ...
In Article Trend: Neutral
February 28, 2024 (11:20) / "Zacks Commentary" (by Zacks Equity Research)

Is Invesco S&P 500 Equal Weight ETF ( RSP ) a Strong ETF Right Now?

Smart Beta ETF report for ...
In Article Trend: Somewhat-Bullish
February 27, 2024 (13:47) / "Benzinga" (by Avi Kapoor)

Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying - Heartland Express ( NASDAQ:HTLD ) , Allegion ( NYSE:ALLE )

Although U.S. stocks closed lower on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
In Article Trend: Somewhat-Bullish
February 27, 2024 (08:09) / "PR Newswire" (by Illumina)

Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China

SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- On February 26, 2024, Illumina Inc. ( NASDAQ: ILMN ) a global leader in DNA sequencing and array-based technologies, announced that Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China, and a member of the global ...
In Article Trend: Bullish
February 27, 2024 (02:00) / "Benzinga" (by Globe Newswire)

ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Illumina ( NASDAQ:ILMN )

NEW YORK, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Illumina, Inc.
In Article Trend: Neutral
February 26, 2024 (23:29) / "Motley Fool" (by Eric Volkman)

Why Illumina Stock Mashed the Market on Monday

Investors usually get more bullish when a top manager buys more heavily into their company.
In Article Trend: Somewhat-Bullish
February 26, 2024 (10:30) / "PR Newswire" (by Research and Markets)

Genetic Testing Markets - Global Market Analysis with Forecasts to 2027: Genetic Testing has Crossed the Chasm and is Now Growing in Every Area

Genetic Testing Markets - Global Market Analysis with Forecasts to 2027: Genetic Testing has Crossed the Chasm and ... PR ...
In Article Trend: Neutral
February 26, 2024 (05:00) / "PR Newswire" (by Armonica Technologies)

Armonica Technologies announces Emily Milsovic joins Board of Directors

SAN DIEGO, Feb. 26, 2024 /PRNewswire/ -- Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of biotech veteran Emily Milsovic to the Board of Directors.
In Article Trend: Somewhat-Bullish
February 23, 2024 (12:43) / "Zacks Commentary" (by Zacks Equity Research)

Veracyte's ( VCYT ) Q4 Loss Widens, Gross Margin Expands

Veracyte's (VCYT) fourth-quarter 2023 performance reflects solid financial discipline and the strength of the Decipher Prostate and Afirma tests.
In Article Trend: Neutral
February 20, 2024 (15:25) / "Zacks Commentary" (by Zacks Equity Research)

Illumina ( ILMN ) Rides on NGS Portfolio Expansion Amid Macro Woe

In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
In Article Trend: Somewhat-Bullish
February 20, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Microarray Scanners Market Size Estimated to Reach US$ 1.7 billion, Rising at a CAGR of 7.5% by 2031: Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 20, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global microarray scanners market is estimated to flourish at a CAGR of 7.5% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
February 18, 2024 (06:50) / "Stocknews.com" (by Defense World Staff)

StockNews.com Upgrades Illumina ( NASDAQ:ILMN ) to Buy

Illumina ( NASDAQ:ILMN - Get Free Report ) was upgraded by equities researchers at StockNews.com from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Friday. ILMN has been the subject of a number of other reports. Sanford C.
In Article Trend: Somewhat-Bullish
February 16, 2024 (06:34) / "Stocknews.com" (by Defense World Staff)

Illumina ( NASDAQ:ILMN ) Upgraded to "Buy" by StockNews.com

Illumina ( NASDAQ:ILMN - Get Free Report ) was upgraded by stock analysts at StockNews.com from a "hold" rating to a "buy" rating in a report issued on Friday. A number of other equities analysts have also weighed in on the stock.
In Article Trend: Somewhat-Bullish
February 15, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Carrier Screening Market is Expected to Reach $5.4 Billion | MarketsandMarkets™

Chicago, Feb. 15, 2024 ( GLOBE NEWSWIRE ) -- Carrier Screening market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $5.4 billion by 2028, growing at a CAGR of 19.7% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
In Article Trend: Somewhat-Bullish
February 12, 2024 (13:00) / "Investors Business Daily" (by Investor's Business Daily)

Investors Ignore Screaming Alarm Saying The S&P 500 Is Overvalued

S&P 500: Investors Ignore Screaming Alarm Saying Stocks Overvalued Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
February 12, 2024 (11:30) / "Benzinga" (by Globe Newswire)

Global Rare Disease Diagnostics Market Size is Estimated to Reach USD 71.2 Billion by 2031, Growing at a CAGR of 8.62%: Straits Research

New York, United States, Feb. 12, 2024 ( GLOBE NEWSWIRE ) -- This study examines the effects of uncommon diseases on a significant portion of the global population. There are over 7000 uncommon diseases, and inadequate information is available for many of them, limiting diagnostic and therapeutic ...
In Article Trend: Neutral
February 9, 2024 (18:18) / "Benzinga" (by Avi Kapoor)

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Take-Two Interactive ( NASDAQ:TTWO )

Shares of Take-Two Interactive Software, Inc. TTWO fell sharply during Friday's session following third-quarter results. Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year.
In Article Trend: Neutral
February 9, 2024 (14:32) / "Benzinga" (by Vandana Singh)

Why Is Illumina Stock Trading Lower Today? - Illumina ( NASDAQ:ILMN )

Thursday, Illumina Inc ILMN reported fourth-quarter 2023 sales of $1.12 billion, up 4% Y/Y, beating the consensus of $1.09 billion. The company reported adjusted EPS of $0.14, surpassing the consensus estimate of $0.02.
In Article Trend: Somewhat-Bullish
February 9, 2024 (14:13) / "CNBC" (by Jim Cramer)

Jim Cramer's top 10 things to watch in the stock market Friday

Stock futures were slightly higher Friday after the S&P 500 briefly surpassed the 5,000 mark during Thursday's trading session.
In Article Trend: Somewhat-Bullish
February 9, 2024 (12:39) / "Zacks Commentary" (by Zacks Equity Research)

Illumina ( ILMN ) Q4 Earnings Surpass Estimates, Margin Down

Illumina (ILMN) Q4 revenues increase year over year, driven by NovaSeq X instrument and consumables sales.
In Article Trend: Neutral
February 9, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Molecular Cytogenetics Market is Expected to Reach $4.9 Billion | MarketsandMarkets™

Chicago, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- Molecular Cytogenetics market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
In Article Trend: Neutral
February 9, 2024 (09:57) / "Benzinga" (by Avi Kapoor)

Expedia Reports Q4 Results, Joins Pinterest, Affirm Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Expedia Group ( NASDAQ:EXPE ) , Pinterest ( NYSE:PINS ) , Affirm Holdings ( NASDAQ:AFRM )

U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 15 points on Friday. Shares of Expedia Group, Inc. EXPE fell sharply in today's pre-market trading after the company reported fourth-quarter financial results and named Ariane Gorin as CEO.
In Article Trend: Neutral
February 8, 2024 (21:05) / "PR Newswire" (by Inc.)

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023

SAN DIEGO, Feb. 8, 2024 /PRNewswire/ -- Illumina, Inc. ( Nasdaq: ILMN ) ( "Illumina" or the "company" ) today announced its financial results for the fourth quarter and fiscal year 2023, which include the consolidated financial results for GRAIL.
In Article Trend: Neutral
February 8, 2024 (19:05) / "Benzinga" (by Piero Cingari)

S&P 500 Tests Resistance At 5,000, ARM Rockets, Oil Rebounds: What's Driving Markets Thursday? - ARM Holdings ( NASDAQ:ARM )

Major U.S. stock averages traded on a mixed note at midday in New York, with the S&P 500 grappling with the psychological resistance level of 5,000, while the tech-heavy Nasdaq 100 managed to reach fresh record highs. On a relatively data-thin day, Federal Reserve officials continued to dominate ...
In Article Trend: Neutral
February 7, 2024 (16:40) / "Zacks Commentary" (by Zacks Equity Research)

HRMY or ILMN: Which Is the Better Value Stock Right Now?

HRMY vs. ILMN: Which Stock Is the Better Value Option?
In Article Trend: Bullish
February 5, 2024 (14:16) / "Zacks Commentary" (by Zacks Equity Research)

Seeking Clues to Illumina ( ILMN ) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Illumina (ILMN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
In Article Trend: Neutral
February 2, 2024 (23:00) / "Investors Business Daily" (by ALAN R. ELLIOTT)

Disney, Caterpillar, McDonald's, Ford: Investing Action Plan

Disney Stock, Caterpillar, McDonald's, Ford: Investing Action Plan Investor's Business Daily ...
In Article Trend: Neutral
February 2, 2024 (15:50) / "Benzinga" (by Globe Newswire)

MicroRNA Market Size is Anticipated to Reach USD 15.5 billion, at a CAGR of 29.4% CAGR by 2033 - Report by Transparency Market Research Inc.

Wilmington, Delaware, United States, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global micro-RNA market is estimated to flourish at a CAGR of 29.4% from 2023 to 2033.
In Article Trend: Somewhat-Bullish
February 1, 2024 (14:00) / "PR Newswire" (by Volta Labs Inc.)

Volta Labs Launches Callisto to Revolutionize Genomics and Sample Prep

BOSTON, Feb. 1, 2024 /PRNewswire/ -- , a genomics applications company, announced today the introduction of the Callisto™ Sample Prep System, a benchtop instrument with many pre-optimized applications that reduces operational requirements and costs in the laboratory and clinic that were ...
In Article Trend: Somewhat-Bullish
January 30, 2024 (06:20) / "Stocknews.com" (by Defense World Staff)

StockNews.com Downgrades Illumina ( NASDAQ:ILMN ) to Hold

Illumina ( NASDAQ:ILMN - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Tuesday. Several other analysts have also recently commented on the company.
In Article Trend: Somewhat-Bullish



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.